Humira Side Effects
How can Humira Side Effects affect You? | PatientsVille.com
View and Submit Humira Side Effects
Your Humira Side Effect submission can play a very important role. Reporting your experience could help identify an unknown risk and inform other patients and health care professionals.
Record and Track Your Side Effects
It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.
Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Alternative HUMIRA Names:ADALIMUMA
Side Effects reported to FDA: 59650. View Humira Adverse Reports
Reported deaths: 2782
Reported hospitalizations: 17828
Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi) August 2009
Audience: Rheumatologists, gastroenterologists, oncologists, dermatologists
[UPDATED 08/31/2009] Supplemental Q&As added
[Posted 08/04/2009] FDA notified healthcare professionals that it has completed its analysis of tumor necrosis factor (TNF) blockers and has concluded that there is an increased risk of lymphoma and other cancers associated with the use of these drugs in children and adolescents. This new safety information is now being added to the Boxed Warning for these products. FDA has also identified new safety information related to the occurrence of leukemia and new-onset psoriasis in patients treated with TNF blockers. The current prescribing information for TNF blockers does contain a warning for malignancies, but does not specifically mention leukemia. FDA is also requiring updates to the current Medication Guide to help patients understand the risks associated with TNF blocker therapy.
TNF blockers are approved for the treatment of one or more of a number of immune system diseases including juvenile idiopathic arthritis (JIA), rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, Crohnâ??s disease, and ankylosing spondylitis.
[08/28/2009 - Q&As - FDA]
Previous MedWatch Alert:
Humira Adverse Reactions
Injection Site Pain ( 5231 Reports)|Incorrect Dose Administered ( 4258 Reports)|Arthralgia ( 3224 Reports)|Pain ( 2600 Reports)|Pyrexia ( 2374 Reports)|Accidental Exposure ( 2344 Reports)|Fatigue ( 2191 Reports)|Headache ( 2158 Reports)|Injection Site Erythema ( 1970 Reports)|Nausea ( 1879 Reports)|Diarrhoea ( 1878 Reports)|Injection Site Irritation ( 1776 Reports)|Crohn's Disease ( 1741 Reports)|Cough ( 1706 Reports)|Abdominal Pain ( 1629 Reports)|Nasopharyngitis ( 1585 Reports)|Psoriasis ( 1577 Reports)|Dyspnoea ( 1562 Reports)|Rash ( 1536 Reports)|Pain In Extremity ( 1460 Reports)|Oedema Peripheral ( 1454 Reports)|Pneumonia ( 1381 Reports)|Rheumatoid Arthritis ( 1309 Reports)|Injection Site Haemorrhage ( 1244 Reports)|Asthenia ( 1238 Reports)|Injection Site Haematoma ( 1216 Reports)|Pruritus ( 1206 Reports)|Dizziness ( 1166 Reports)|Injection Site Pruritus ( 1154 Reports)|Vomiting ( 1149 Reports)|